β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (574) π οΈ Industry Q&A (121) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ€ Insider Trades
| Date | Type | Name | A/D | Amount | Price | Security |
|---|---|---|---|---|---|---|
| 2026-04-01 | S-Sale | Sandercock Brett officer: Chief Financial Officer |
D | 1000 | 224.31 | ResMed Common Stock |
| 2026-04-01 | S-Sale | FARRELL PETER C director |
D | 2000 | 225 | ResMed Common Stock |
| 2026-03-09 | M-Exempt | Farrell Michael J. director, officer: Chairman and CEO |
D | 4991 | 146.34 | ResMed Common Stock Options |
| 2026-03-04 | S-Sale | FARRELL PETER C director |
D | 2000 | 260.22 | ResMed Common Stock |
| 2026-03-02 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-02-09 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-02-04 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-02-04 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-02-02 | ***** | ***** |
***** | ***** | ***** | ***** |
ποΈ Explore more insider trade data for ResMed!
Sign up for free or log inπ Get insights from "The Checklist Value Investor β A Smarter Way to Pick Stocks" now!